AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29933343 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded Exercise Therapy (GET) and Resistance Training (RT) program, 12 months duration, exercise sessions at 6 days per week, aerobic exercises with incremental training time, resistance exercises with a durable resistance band.
Number of subjects: 60
Study 29933343 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving usual out-patient care, n = 117.
Number of subjects: 60
Study 27825334 — intervention group
Group type: EXPERIMENTAL
Intervention: Danlou tablets
Number of subjects: 83
Study 27825334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 24871808 — intervention group
Group type: EXPERIMENTAL
Intervention: Reference mometasone
Number of subjects: 402
Study 24871808 — intervention group
Group type: EXPERIMENTAL
Intervention: Test mometasone
Number of subjects: 402
Study 24871808 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 402
Study 23157761 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal referrals + telephone health coach/navigator
Number of subjects: 1200
Study 23157761 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal referrals + tailored reminder mailed to their home
Number of subjects: 1200
Study 23157761 — intervention group
Group type: COMPARATOR
Intervention: Verbal referrals only
Number of subjects: 1200
Study 20675411 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia
Number of subjects: 100
Study 20675411 — intervention group
Group type: COMPARATOR
Intervention: Propofol anesthesia
Number of subjects: 100
Study 17513394 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 g avenanthramide-enriched mixture (AEM)
Number of subjects: 6
Study 17513394 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g avenanthramide-enriched mixture (AEM)
Number of subjects: 6
Study 17513394 — intervention group
Group type: COMPARATOR
Intervention: 360 mL skim milk (placebo)
Number of subjects: 6
Study 16156111 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl HCl PCTS (25 microg) for 23.33 hours
Number of subjects: 104
Study 16156111 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl HCl PCTS (40 microg) for 23.33 hours
Number of subjects: 104
Study 16156111 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl HCl PCTS (40 microg) for 20 hours followed by 68 hours
Number of subjects: 104
Study 16156111 — intervention group
Group type: COMPARATOR
Intervention: IV fentanyl (80 microg/h) administered intermittently over 24 hours
Number of subjects: 104
Study 12117882 — intervention group
Group type: EXPERIMENTAL
Intervention: L‐NMMA
Number of subjects: 18
Study 12117882 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 10548606 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonal-F (150 IU/day)
Number of subjects: 348
Study 10548606 — intervention group
Group type: EXPERIMENTAL
Intervention: Puregon (150 IU/day)
Number of subjects: 348
Study 10548606 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonal-F (300 IU/day)
Number of subjects: 348
Study 10548606 — intervention group
Group type: EXPERIMENTAL
Intervention: Puregon (300 IU/day)
Number of subjects: 348
Study 10548606 — intervention group
Group type: COMPARATOR
Intervention: Gonal-F
Number of subjects: 348
Study 10548606 — intervention group
Group type: COMPARATOR
Intervention: Puregon
Number of subjects: 348
Study 7842204 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 62
Study 7842204 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilevel Positive Airway Pressure
Number of subjects: 62
Study 7842204 — intervention group
Group type: COMPARATOR
Intervention: Control (not explicitly mentioned)
Number of subjects: 62
Study 2384768 — intervention group
Group type: EXPERIMENTAL
Intervention: Duo Formula Group (DFG) self-care programme
Number of subjects: 59
Study 2384768 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 59
Study 320990 — intervention group
Group type: EXPERIMENTAL
Intervention: NAB 365
Number of subjects: 0
Study 320990 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 0
Study 31472003 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive strategy (oral calcium + vitamin D supplementation)
Number of subjects: 169
Study 31472003 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive strategy (therapy in hypocalcemia)
Number of subjects: 169
Study 31472003 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive strategy (therapy if iPTH <10 pg/mL)
Number of subjects: 169
Study 31472003 — intervention group
Group type: EXPERIMENTAL
Intervention: Total serum calcium (TSCa)
Number of subjects: 169
Study 31472003 — intervention group
Group type: EXPERIMENTAL
Intervention: Ionized calcium (ICa)
Number of subjects: 169
Study 31472003 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact parathyroid hormone (iPTH)
Number of subjects: 169
Study 28449795 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan (target dose 125 mg twice daily)
Number of subjects: 1613
Study 28449795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1613
Study 28449795 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan
Number of subjects: 1613
Study 24658022 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 55
Study 24658022 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 55
Study 24658022 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 55
Study 24054398 — intervention group
Group type: EXPERIMENTAL
Intervention: Terazosine plus propiverine HCL
Number of subjects: 100
Study 24054398 — intervention group
Group type: COMPARATOR
Intervention: Terazosine and placebo
Number of subjects: 100
Study 20933466 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 415
Study 20933466 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (radiotherapy plus immediate androgen suppression with goserelin acetate)
Number of subjects: 415
Study 18355913 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 Gy in 15 fractions of 2.67 Gy over 3 weeks
Number of subjects: 2215
Study 18355913 — intervention group
Group type: COMPARATOR
Intervention: 50 Gy in 25 fractions of 2.0 Gy over 5 weeks
Number of subjects: 2215
Study 17137013 — intervention group
Group type: EXPERIMENTAL
Intervention: Gymnastics once a week
Number of subjects: 386
Study 17137013 — intervention group
Group type: EXPERIMENTAL
Intervention: Gymnastics twice a week
Number of subjects: 386
Study 17137013 — intervention group
Group type: COMPARATOR
Intervention: Health educational program
Number of subjects: 386
Study 12715790 — intervention group
Group type: EXPERIMENTAL
Intervention: Edaravone (30 mg, twice a day for 14 days)
Number of subjects: 252
Study 12715790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252
Study 11073322 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan/oil rinse
Number of subjects: 24
Study 11073322 — intervention group
Group type: COMPARATOR
Intervention: Control rinse
Number of subjects: 24
Study 9176190 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone administration at 9:30 PM
Number of subjects: 9
Study 7844498 — intervention group
Group type: EXPERIMENTAL
Intervention: TV stimulus programs with frequent risk-taking
Number of subjects: 50
Study 7844498 — intervention group
Group type: COMPARATOR
Intervention: TV stimulus programs with infrequent physical risk-taking
Number of subjects: 50
Study 7844498 — intervention group
Group type: COMPARATOR
Intervention: No TV stimuli
Number of subjects: 50
Study 3058171 — intervention group
Group type: EXPERIMENTAL
Intervention: FUT‐175 (protease inhibitor)
Number of subjects: 157
Study 3058171 — intervention group
Group type: COMPARATOR
Intervention: Regional heparinization (RH)
Number of subjects: 157
Study 3058171 — intervention group
Group type: COMPARATOR
Intervention: Low dose heparinization (LH)
Number of subjects: 157
Study 31226679 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of occipital condyle‐C1 interval (CCI)
Number of subjects: 1458
Study 31226679 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of atlantodental interval (ADI)
Number of subjects: 1458
Study 31226679 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of basion‐dens interval (BDI)
Number of subjects: 1458
Study 31226679 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of pB‐C2
Number of subjects: 1458
Study 31226679 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of PADI
Number of subjects: 1458
Study 31226679 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of basion‐axial interval (BAI)
Number of subjects: 1458
Study 31226679 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of basion‐opisthion diameter (BOD)
Number of subjects: 1458
Study 31226679 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of dens angulation
Number of subjects: 1458
Study 31226679 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of canal diameter at C1
Number of subjects: 1458
Study 27237928 — intervention group
Group type: EXPERIMENTAL
Intervention: CFT + TAU
Number of subjects: 22
Study 27237928 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 22
Study 28700832 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week low-carbohydrate, high-fat diet
Number of subjects: 41
Study 28700832 — intervention group
Group type: COMPARATOR
Intervention: Conventional high-carbohydrate, low-fat diet
Number of subjects: 41
Study 24227721 — intervention group
Group type: EXPERIMENTAL
Intervention: Activation in motor response control regions
Number of subjects: 123
Study 24227721 — intervention group
Group type: EXPERIMENTAL
Intervention: Activation in executive control regions
Number of subjects: 123
Study 24227721 — intervention group
Group type: EXPERIMENTAL
Intervention: Error-processing activation in the dorsal anterior cingulate cortex
Number of subjects: 123
Study 21343330 — intervention group
Group type: EXPERIMENTAL
Intervention: Family psychoeducation (4 sessions of didactic lectures and group problem-solving)
Number of subjects: 57
Study 21343330 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control group)
Number of subjects: 57
Study 19574662 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping applied with tension
Number of subjects: 41
Study 19574662 — intervention group
Group type: COMPARATOR
Intervention: Sham Kinesio Taping applied without tension
Number of subjects: 41
Study 18264542 — intervention group
Group type: EXPERIMENTAL
Intervention: Open surgery
Number of subjects: 359
Study 18264542 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic repair
Number of subjects: 359
Study 15519187 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin dosage of 100 iu/kg
Number of subjects: 195
Study 15519187 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin dosage of 200 iu/kg
Number of subjects: 195
Study 15519187 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin dosage of 250 iu/kg
Number of subjects: 195
Study 15519187 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin dosage of 300 iu/kg
Number of subjects: 195
Study 11212998 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based model of continuity of care (n = 550)
Number of subjects: 1089
Study 11212998 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital-based care (n = 539)
Number of subjects: 1089
Study 8616834 — intervention group
Group type: EXPERIMENTAL
Intervention: GSTM3 AA genotype
Number of subjects: 586
Study 8616834 — intervention group
Group type: EXPERIMENTAL
Intervention: GSTM3 AA in combination with skin type 1, GSTM1 null, and CYP1A1 m1m1
Number of subjects: 586
Study 8616834 — intervention group
Group type: EXPERIMENTAL
Intervention: GSTM3 BB genotype
Number of subjects: 586
Study 8616834 — intervention group
Group type: EXPERIMENTAL
Intervention: GSTM1 A/B genotype
Number of subjects: 586
Study 1611985 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg midazolam
Number of subjects: 150
Study 1611985 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg midazolam, 1.5 mg/kg tramadol, 50 mg alizaprid
Number of subjects: 150
Study 1611985 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg midazolam, 0.2 mg/kg nalbuphine, 50 mg alizaprid
Number of subjects: 150
Study 4030188 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone and anabolic steroids (average 57 +/- 24.9 mg/day for 6 months)
Number of subjects: 11
Study 4030188 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone and anabolic steroids
Number of subjects: 11
Study 4030188 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 11
Study 31664592 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover design with interleaving cohorts
Number of subjects: 0
Study 31664592 — intervention group
Group type: COMPARATOR
Intervention: Parallel group design
Number of subjects: 0
Study 31664592 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover designs
Number of subjects: 0
Study 31664592 — intervention group
Group type: COMPARATOR
Intervention: All evaluated designs
Number of subjects: 0
Study 30586364 — intervention group
Group type: EXPERIMENTAL
Intervention: Maraviroc alone or together with TDF or FTC
Number of subjects: 591
Study 30586364 — intervention group
Group type: COMPARATOR
Intervention: TDF + FTC (control)
Number of subjects: 591
Study 27993145 — intervention group
Group type: EXPERIMENTAL
Intervention: High-specification foam mattress
Number of subjects: 2954
Study 27993145 — intervention group
Group type: COMPARATOR
Intervention: Alternating-pressure mattress
Number of subjects: 2954
Study 24337350 — intervention group
Group type: EXPERIMENTAL
Intervention: LED therapy (λ of 640 ± 20 nm and spatial average energy fluency of 1.2 J/cm(2) during hospitalization)
Number of subjects: 90
Study 24337350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 24337350 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study 24337350 — intervention group
Group type: EXPERIMENTAL
Intervention: LED therapy (640 nm)
Number of subjects: 90
Study 22371093 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone-conducted music using the SwiMP3 device
Number of subjects: 24
Study 19590469 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation course (MMC)
Number of subjects: 33
Study 19590469 — intervention group
Group type: COMPARATOR
Intervention: Leadership course (control)
Number of subjects: 33
Study 17878877 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation for HCC contacting large vessels (Group A)
Number of subjects: 26
Study 17878877 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation for HCC away from large vessels (Group B)
Number of subjects: 26
Study 15223187 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with frontotemporal dementia
Number of subjects: 0
Study 15223187 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 0
Study 11245839 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention-based visual routines involving dynamic patterns (e.g., pairs of points in orbiting motion, 11 points in biological motion)
Number of subjects: 0
Study 9675625 — intervention group
Group type: EXPERIMENTAL
Intervention: Low doses of morphine
Number of subjects: 0
Study 9675625 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 0
Study 9675625 — intervention group
Group type: COMPARATOR
Intervention: Naloxone
Number of subjects: 0
Study 10381659 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium ointment (10% w/w calcium carbonate) applied to lower lid skin twice a day
Number of subjects: 0
Study 10381659 — intervention group
Group type: COMPARATOR
Intervention: Petrolatum without calcium carbonate (control)
Number of subjects: 0
Study 2240692 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene Leader‐Cath 115‐09 catheter (group A)
Number of subjects: 48
Study 2240692 — intervention group
Group type: COMPARATOR
Intervention: Teflon Viggo Floswitch 4441 catheter (group B)
Number of subjects: 48
Study 720774 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (10 gm over four days)
Number of subjects: 2
Study 720774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 720774 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen and ketoprofen
Number of subjects: 2
Study 31121294 — intervention group
Group type: EXPERIMENTAL
Intervention: Cane group (using a cane whenever walking)
Number of subjects: 79
Study 31121294 — intervention group
Group type: COMPARATOR
Intervention: Control group (not using any gait aid)
Number of subjects: 79
Study 27334026 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group discussions
Number of subjects: 28
Study 27334026 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire assessing knowledge on FV intake guidelines
Number of subjects: 28
Study 25677271 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic colectomy
Number of subjects: 56
Study 25677271 — intervention group
Group type: EXPERIMENTAL
Intervention: Open colectomy
Number of subjects: 56
Study 25677271 — intervention group
Group type: COMPARATOR
Intervention: Cholecystectomy
Number of subjects: 56
Study 25677271 — intervention group
Group type: EXPERIMENTAL
Intervention: Colectomy patients developing POI
Number of subjects: 56
Study 23314117 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 min of video-based training
Number of subjects: 0
Study 23314117 — intervention group
Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 0
Study 23314117 — intervention group
Group type: COMPARATOR
Intervention: Self-ratings of performance
Number of subjects: 0
Study 23314117 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-ratings of performance after training
Number of subjects: 0
Study 21527597 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) plus 2 months of Tube Feeding (TF)
Number of subjects: 103
Study 21527597 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT) alone
Number of subjects: 103
Study 19253241 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrobulbar block (group R)
Number of subjects: 81
Study 19253241 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-Tenon block (group S)
Number of subjects: 81
Study 19253241 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthesia (group T)
Number of subjects: 81
Study 16952507 — intervention group
Group type: EXPERIMENTAL
Intervention: Sperm cryopreservation using a standard protocol with a test-yolk buffer, glycerol as the cryoprotectant
Number of subjects: 77
Study 15041988 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape
Number of subjects: 50
Study 15041988 — intervention group
Group type: COMPARATOR
Intervention: Plication of the endopelvic fascia
Number of subjects: 50
Study 11747472 — intervention group
Group type: COMPARATOR
Intervention: Horse-chestnut seeds extract (HCSE) and compression therapy
Number of subjects: 0
Study 11747472 — intervention group
Group type: COMPARATOR
Intervention: Compression therapy
Number of subjects: 0
Study 11747472 — intervention group
Group type: EXPERIMENTAL
Intervention: Horse-chestnut seeds extract (HCSE)
Number of subjects: 0
Study 9230168 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 hours of bed rest after coronary arteriography
Number of subjects: 0
Study 9230168 — intervention group
Group type: COMPARATOR
Intervention: 6 hours of bed rest after coronary arteriography
Number of subjects: 0
Study 8232429 — intervention group
Group type: EXPERIMENTAL
Intervention: CHVP plus interferon alfa (5 million units three times weekly for 18 months)
Number of subjects: 242
Study 8232429 — intervention group
Group type: EXPERIMENTAL
Intervention: CHVP plus interferon alfa
Number of subjects: 242
Study 8232429 — intervention group
Group type: COMPARATOR
Intervention: CHVP alone
Number of subjects: 242
Study 3662273 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital (FB)
Number of subjects: 17
Study 3662273 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin (DPH)
Number of subjects: 17
Study 31718842 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg monthly
Number of subjects: 1097
Study 31718842 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg pro re nata (PRN) after 3 loading doses
Number of subjects: 1097
Study 31718842 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 2.0 mg monthly
Number of subjects: 1097
Study 31718842 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 2.0 mg PRN
Number of subjects: 1097
Study 31718842 — intervention group
Group type: COMPARATOR
Intervention: All ranibizumab doses
Number of subjects: 1097
Study 29315411 — intervention group
Group type: EXPERIMENTAL
Intervention: CLOSE-guided PVI
Number of subjects: 50
Study 29315411 — intervention group
Group type: COMPARATOR
Intervention: CONV-CF
Number of subjects: 50
Study 29110687 — intervention group
Group type: COMPARATOR
Intervention: High-frequency rTMS (5 Hz) over the bilateral lower-limb motor area (Cz), 10 sessions.
Number of subjects: 20
Study 29110687 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS (control group).
Number of subjects: 20
Study 26330595 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar locking plate (n = 66)
Number of subjects: 130
Study 26330595 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous fixation (n = 64)
Number of subjects: 130
Study 26330595 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar locking plate
Number of subjects: 130
Study 26330595 — intervention group
Group type: COMPARATOR
Intervention: Volar locking plate relative to percutaneous fixation
Number of subjects: 130
Study 22633653 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 346
Study 22633653 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 346
Study 20546157 — intervention group
Group type: EXPERIMENTAL
Intervention: Transseptal (TS) approach
Number of subjects: 22
Study 20546157 — intervention group
Group type: COMPARATOR
Intervention: Transaortic (TA) approach
Number of subjects: 22
Study 18502781 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerine (IV 0.5 microg/kg/min for 20 min; n = 27)
Number of subjects: 32
Study 18502781 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 5)
Number of subjects: 32
Study 18502781 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerine (IV 0.5 microg/kg/min for 20 min)
Number of subjects: 32